Citadel: Retail Investors Net Sold U.S. Stocks and Options Last Week, Historical Data Suggests Strong Rally Ahead
BlockBeats News, April 7th: Citadel Securities reported that retail investors net sold U.S. stocks and options last week, contrasting with a rare trend of continuous buying over the years.
Net outflows in March decreased by 55% compared to February and by 70% compared to the peak in January. Options activity shifted towards defensive positions, showing an increased demand for downside protection.
Historically, this kind of retail selling behavior has often foreshadowed a strong short-term rally in the S&P 500 index, with an average increase of 4.1% over two months. This shift comes against the backdrop of rising oil prices in March and market turbulence triggered by the Iran conflict, resulting in a 5% year-to-date decline in the S&P 500 index and an 80% increase in Brent crude oil prices.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
